J.P. Marvel Investment Advisors, LLC Vertex Pharmaceuticals Inc Transaction History
J.P. Marvel Investment Advisors, LLC
- $607 Million
- Q2 2024
A detailed history of J.P. Marvel Investment Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, J.P. Marvel Investment Advisors, LLC holds 6,392 shares of VRTX stock, worth $2.91 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
6,392
Previous 6,392
-0.0%
Holding current value
$2.91 Million
Previous $2.67 Million
12.17%
% of portfolio
0.49%
Previous 0.46%
Shares
4 transactions
Others Institutions Holding VRTX
# of Institutions
1,706Shares Held
225MCall Options Held
1.2MPut Options Held
1.59M-
Capital World Investors Los Angeles, CA26.7MShares$12.2 Billion2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA23MShares$10.5 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.7 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$5.34 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA8.54MShares$3.89 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $117B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...